The Brain-Heart Axis: Alzheimer's, Diabetes, and Hypertension

Andrew S Riching1,2, Jennifer L Major1,2, Pilar Londono3

  • 1Department of Medicine, Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, United States.

Insights

Alzheimer's disease (AD) may be a form of Type III Diabetes (T3D). Treatments for Type II Diabetes (T2D), like metformin, show promise for improving cognitive function and preventing AD.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Cardiovascular Science

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder with limited treatment options.
  • Current AD drug development targeting brain pathologies (plaques and tangles) has faced significant clinical trial failures.
  • Emerging research suggests a strong link between AD and Type II Diabetes (T2D), proposing AD as a brain-specific manifestation termed Type III Diabetes (T3D).

Purpose of the Study:

  • To review current research and clinical trials for Alzheimer's disease.
  • To explore the potential of Type II Diabetes (T2D) treatments for Alzheimer's disease (AD).
  • To highlight the systemic nature of AD, involving the brain-heart axis and its regulation of hypertension and diabetes.

Main Methods:

  • Literature review of past and ongoing research in Alzheimer's disease (AD).
  • Analysis of studies investigating the link between Type II Diabetes (T2D) and neurodegenerative disorders.
  • Examination of research on the brain-heart axis, hypertension, and diabetes in relation to cognitive function.

Main Results:

  • Type II Diabetes (T2D) medications, such as metformin, demonstrate potential in enhancing cognitive function and preventing Alzheimer's disease (AD) in diabetic individuals.
  • The brain and cardiovascular system communicate via the vasculature, influencing fluid and nutrient balance.
  • The brain-heart axis plays a role in regulating hypertension and diabetes, both critical factors affecting cognitive health.

Conclusions:

  • Alzheimer's disease (AD) is increasingly viewed as a complex, systemic disorder rather than solely a brain-centric condition.
  • Treatments targeting Type II Diabetes (T2D) show promise for managing Alzheimer's disease (AD) symptoms and progression.
  • Comprehensive therapeutic strategies addressing systemic factors, including the brain-heart axis, are crucial for effective Alzheimer's disease (AD) prevention and treatment.

Related Concept Videos

Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
362
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
623
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
1.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
594
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
785